Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 23, 2019
The FDA and the FTC posted a joint warning letter to Rooted Apothecary for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims.
read more
Wednesday, October 23, 2019
Ambrx and NovoCodex Biopharmaceuticals have formed a second collaboration to develop and commercialize Ambrx's internally developed site-specific antibody drug conjugates.
read more
Tuesday, October 22, 2019
UPS announced numerous new technology-enabled services and partnerships.
read more
Tuesday, October 22, 2019
Metrics Contract Services has completed the installation of a new high shear mixer from ACG Engineering at its facility in Greenville, North Carolina.
read more
Tuesday, October 22, 2019
4G Clinical announced its recognition as the BSMA Supply Chain Management Excellence and Innovation Award 2019 recipient for its utilization of NLP to turn study parameters into detailed forecasts.
read more
Omnicell announced Med Center Health has signed a sole source agreement to partner with Omnicell to streamline and secure its medication management process.
read more
The Pharmaceutical Research and Manufacturers of America (PhRMA) appointed new leadership to its board of directors.
read more
Bora has announced the opening of its first North American office in Delaware, U.S.
read more
Sartorius has signed an agreement to acquire parts of Danaher’s Life Science portfolio for approximately $750 million in cash.
read more
Alkermes has entered into a clinical research collaboration with Fred Hutchinson Cancer Research Center for ALKS 4230, Alkermes' immuno-oncology drug candidate.
read more
Foamix, together with LEO, has entered into a settlement and license agreement with an affiliate of Teva to resolve pending patent litigation involving Finacea® Foam.
read more
Selexis and Teneobio have signed three commercial license agreements (CLAs) for the development of Teneobio’s Human Heavy-Chain.
read more
Thermo Fisher Scientific announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel.
read more
Simulations Plus has entered into a new funded collaboration with a large pharmaceutical company to develop the Virtual Bioequivalence (BE) Trial Simulator™ in GastroPlus®.
read more
Worldwide Clinical Trials has implemented ClinSpark®, the eSource platform for Phase I clinical trial automation by Foundry Health.
read more